Results 161 to 170 of about 11,703 (213)

Repurposing the SSRI paroxetine increases lymphocyte mobilization and improves the efficacy of measles virus-based immunovirotherapy. [PDF]

Mol Ther Oncol
Stergiopoulos GM, Concilio SC, Viker KB, Clark SM, Robinson SI, Galanis E.   +5 more
europepmc   +1 more source

Fusing Oncolytic Virotherapy With Cancer Immunotherapy to Treat Therapy-Resistant Melanoma. [PDF]

J Clin Oncol
Vile RG.
europepmc   +1 more source

Polio virotherapy provokes MDA5 signaling and CD4⁺ T cell help to mediate cancer <i>in situ</i> vaccination. [PDF]

Microbiol Mol Biol Rev
Gromeier M, Brown MC.
europepmc   +1 more source

Alphavirus replicons encoding IFN-γ enhance cancer virotherapy by overcoming macrophage-mediated suppression. [PDF]

iScience
Horvathova L, Kinderman P, Janzen T, Hoogeboom BN, Weissing FJ, van Montfoort N, Daemen T, Bhatt DK.   +7 more
europepmc   +1 more source

Engineering antibody-armed oncolytic viruses: design strategies, synergistic mechanisms, and clinical translation. [PDF]

Front Immunol
Kang X, Yang X, Wu H, Tong X, Wang S.
europepmc   +1 more source

Bibliometric evaluation of research trends and hotspots concerning the interaction between immune checkpoint inhibitors and glioma. [PDF]

Discov Oncol
Xu D, He L, Zhao X, Yang Z.
europepmc   +1 more source

Oncolytic viruses in head and neck cancers: clinical applications and therapeutic potential. [PDF]

Front Microbiol
Gupta A, Chavan SR, Gadepalli R, Pareek P.   +3 more
europepmc   +1 more source

Intrinsic immune properties of carrier MSC impact on the clinical outcome of children with solid tumors receiving oncolytic virotherapy. [PDF]

Exp Hematol Oncol
Morales-Molina A, Franco-Luzón L, Garcia-Rodriguez P, González-Murillo A, García-Castro J, Ramírez M.   +5 more
europepmc   +1 more source

Oncovirus classification and insights into herpes simplex virus, Varicella-Zoster virus. [PDF]

Cancer Cell Int
Ghaemi A, Sadeh S.
europepmc   +1 more source